By Devika Patel
Knoxville, Tenn., June 26 - Anavex Life Sciences Corp. completed a $1.12 million private placement of units on June 19, according to an 8-K filed Friday with the Securities and Exchange Commission.
The company sold 495,556 units of one common share and one eighth-share warrant at $2.25 per unit.
Each whole two-year warrant will be exercisable at $2.25.
Based in Geneva, Anavex is focused on developing and marketing drug targets for the treatment of cancer and diseases of the central nervous system.
| Issuer: | Anavex Life Sciences Corp.
|
| Issue: | Units of one common share and one eighth-share warrant
|
| Amount: | $1,115,001
|
| Units: | 495,556
|
| Price: | $2.25
|
| Warrants: | One eighth-share warrant per unit
|
| Warrant expiration: | Two years
|
| Warrant strike price: | $2.25
|
| Settlement date: | June 19
|
| Stock symbol: | OTCBB: AVXL
|
| Stock price: | $2.40 at close June 19
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
